Gold Pacific Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Ellim Corporation Co., Ltd. and other investors
October 18, 2021
Share
Gold Pacific Co., Ltd. announced a private placement of series 26 unregistered nonguaranteed coupon private convertible bonds for a gross proceeds of KRW 20,000,000,000 on October 19, 2021. The bonds have a coupon rate of 1% and yield to maturity of 2%. The bonds will mature on November 24, 2024. The bonds will be converted into 10,863,661 common shares for an equity stake of 12.54%. The transaction has been approved by the board of directors of the company. The transaction will include participation from Fair investment association for KRW 7,000,000,000, Value Oriented Investment Association for KRW 7,000,000,000, Multo Co., Ltd. for KRW 4,000,000,000, Ellim Corporation Co., Ltd. for KRW 1,000,000,000, Ahn, Ki-joon for KRW 500,000,000, Namyoung Nam for KRW 500,000,000.
On June 24, 2022, the company announced that now the bonds will be convertible into 15,514,592 common shares at a conversion price of KRW 651 per share.
On September 26, 2022, the company announced that now the bonds will be convertible into 18,634,686 common shares at a conversion price of KRW 542 per share.
KBio Company Inc, formerly Gold Pacific Co Ltd, is a Korea-based company primarily engaged in the bio distribution business. The Company operates its business through three segments. The Bio Distribution segment is engaged in the supply of research reagents and consumables to each customer through hospitals, universities, research institutes, and dealers. The Fashion segment is engaged in the production and sale of products such as handmade leather goods, clothing, and accessories. The Other segment is engaged in the fashion promotion business and other businesses.
KBIO COMPANY INC. 
